Effectiveness, Safety, and Costs of Dolutegravir/Abacavir/Lamivudine Single-Tablet Regimen in a Real-Life Cohort of HIV-1 Adult Infected Patients.

Conclusion and Relevance: DTG/ABC/3TC is an effective strategy as first-line and switching ART. Our data suggest a worse tolerance in ART-naive patients, although the rate of discontinuation resulting from NP-AEs was relatively low. In the short-term, the adherence was slightly improved without significant changes in costs. PMID: 31910643 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31910643?dopt=Abstract

Source: The Annals of Pharmacotherapy - January 7, 2020 Category: Drugs & Pharmacology Authors: Rodriguez-Gonzalez CG, Chamorro-de-Vega E, Ortega-Navarro C, Alonso R, Herranz-Alonso A, Sanjurjo-Saez M Tags: Ann Pharmacother Source Type: research